Next Article in Journal
Modified Pentylenetetrazole Model for Acute Seizure Induction in Rats
Previous Article in Journal
A Prognostic Neuromodulation-Related Gene Signature Identifies Immunomodulation and Tumour-Associated Hallmarks in Glioblastoma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 13
Issue 11
10.3390/biomedicines13112641
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Retraction of Biomedicines 2022, 10(4), 795.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795

by
Thangirala Sudha
1,
Kavitha Godugu
1,
Gennadi V. Glinsky
2 and
Shaker A. Mousa
1,*
1
The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA
2
Institute of Engineering in Medicine, University of California, San Diego, CA 92093, USA
*
Author to whom correspondence should be addressed.
Biomedicines 2025, 13(11), 2641; https://doi.org/10.3390/biomedicines13112641
Submission received: 23 September 2025 / Accepted: 13 October 2025 / Published: 28 October 2025
(This article belongs to the Section Cancer Biology and Oncology)
Versions Notes
The journal retracts the article “Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer” [1] cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of and images presented in this publication [1].
Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board that identified indications of inappropriate editing and similarities among the subfigures presented in Figure 3. While the authors collaborated within this process, the raw material meeting the journal’s requirements for original images could not be provided for Editorial Board evaluation. Consequently, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication, as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the journal Biomedicines. The authors did not provide a comment on this decision.

Reference

  1. Sudha, T.; Godugu, K.; Glinsky, G.V.; Mousa, S.A. RETRACTED: Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sudha, T.; Godugu, K.; Glinsky, G.V.; Mousa, S.A. RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795. Biomedicines 2025, 13, 2641. https://doi.org/10.3390/biomedicines13112641

AMA Style

Sudha T, Godugu K, Glinsky GV, Mousa SA. RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795. Biomedicines. 2025; 13(11):2641. https://doi.org/10.3390/biomedicines13112641

Chicago/Turabian Style

Sudha, Thangirala, Kavitha Godugu, Gennadi V. Glinsky, and Shaker A. Mousa. 2025. "RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795" Biomedicines 13, no. 11: 2641. https://doi.org/10.3390/biomedicines13112641

APA Style

Sudha, T., Godugu, K., Glinsky, G. V., & Mousa, S. A. (2025). RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795. Biomedicines, 13(11), 2641. https://doi.org/10.3390/biomedicines13112641

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop